Navigation Links
Reducing the side effects of treatment for prostate cancer
Date:8/27/2012

New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen used to treat breast cancer, is also able to suppress gynecomastia and breast pain in men.

Prostate cancer is one of the most common cancers in men and early treatment is usually very successful. Androgen-suppression therapy is often used to slow down progression of advanced disease. However, unwanted side effects of anti-androgen treatment, such as breast enlargement, can stop men from seeking treatment for their cancer.

Testosterone can drive the growth of prostate cancer and anti-androgens are used to inhibit prostate cancer growth by preventing testosterone from binding to androgen receptors. But receptors in cells within the testes are also blocked and start to make more testosterone to compensate. Some of this extra testosterone is converted into estrogen which is responsible for development of breast tissue and other breast events. Anti-estrogens work by jamming the estrogen receptor, while aromatase inhibitors prevent the conversion of testosterone into estrogen.

A collaboration between the German Cochrane Center and University Clinic Erlangen combined data from four independent clinical trials each looking at the management of breast events (during treatment for prostate cancer) with tamoxifen.

A meta-analysis of all four trials showed that tamoxifen reduced the risk of both gynecomastia and breast pain at 3, 6, 9, and 12 months of treatment compared to men who received no treatment. Overall, treatment with tamoxifen was more successful in reducing breast symptoms than treatment with an aromatase inhibitor (anastrazole) or radiotherapy.

Although there is no long term data available, few of the men treated with tamoxifen, either as preventative or therapeutic treatment, stopped taking their medication during their year of treatment. There were also no significant adverse effects.

Dr Frank Kunath, who led this study explained, "Not all men will suffer gynecomastia during anti-androgen therapy. However, if men know that there is a successful option for reducing the breast symptoms associated with treatment for prostate cancer they may be more likely to see their doctor when symptoms of cancer first appear, and consequently reduce the number of unnecessary deaths."


'/>"/>
Contact: Hilary Glover
hilary.glover@biomedcentral.com
44-020-319-22370
BioMed Central
Source:Eurekalert

Related medicine news :

1. Researchers determine vitamin D blood level for reducing major medical risks in older adults
2. Reducing post-traumatic stress after ICU
3. Reducing off-label use of antipsychotic medications may save money
4. No Progress in Reducing U.S. Motorcycle Deaths: Report
5. Kitchen exhaust fans vary in effectiveness in reducing indoor air pollution
6. HPV Vaccine Reducing Infections, Even Among Unvaccinated: Study
7. A nursing program shows promise for reducing deaths from chronic illnesses
8. Reducing Ozone Limits Would Save Lives, Report States
9. Timing of antibiotics important in reducing infections after C-section
10. Young girls more likely to report side effects after HPV vaccine
11. Preteens More Likely to Report HPV Vaccine Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... ... Author Michèle Wolff has a passion for using food as medicine . ... it for optimal health. Wanting to share her knowledge to the world, she debuts ... ” (published by Balboa Press AU). , This book inspires readers to discover ...
(Date:2/21/2017)... ... February 21, 2017 , ... Robins & Morton celebrated ... Oklahoma, on Feb. 21. , The celebration began with a ribbon cutting event ... the construction team and tribal leadership. , Choctaw Nation Durant Regional Medical ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... five new hospital-grade power extension cords that meet the most current standards. , ... 2012 edition of the National Fire Protection Association (NFPA) 101 – Life Safety ...
(Date:2/21/2017)... ... February 21, 2017 , ... Hanna ... director at PolicyLink, will be the keynote speaker at its second Professional Networking ... of Color Framework, which develops comprehensive strategies to create and expand opportunities for ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... Doctors on ... CA, directed by Dr. Kendell Mendonca , to its growing network of doctors ... injuries including injuries stemming from car accidents such as whiplash, back pain, neck pain, ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017 ... equipment with specialized versions are used to monitor physiological ... or as remote patient monitors. Remote patient monitoring is ... of the patient monitoring equipment in the market. Hence, ... integrated with smartphones and applications, which can send test ...
(Date:2/21/2017)... , Feb. 21, 2017 Mass ... report: http://www.reportlinker.com/p04711309-summary/view-report.html This report ... well as future prospects of the market globally. ... intermediaries engaged in the manufacture and commercialization of ... as new entrants planning to enter this market. ...
(Date:2/21/2017)... YORK , Feb. 21, 2017 ... the full report: http://www.reportlinker.com/p04711314-summary/view-report.html ... invasive lesion in hospitals, specialty clinics and ambulatory ... with hydrophilic coating tip. The selection of micro ... location of lesion in human body. Micro guide ...
Breaking Medicine Technology: